Javascript must be enabled to continue!
Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing
View through CrossRef
AbstractThe objective of our study was to compare Movement Disorder Society Task Force criteria for diagnosis of Parkinson's disease dementia (PDD) with the gold standard of traditional neuropsychological testing. A short checklist (Level I) and a protocol of neuropsychological tests (Level II) have been proposed by a Movement Disorder Society Task Force but not fully validated in clinical practice. Ninety‐one Parkinson's disease (PD) subjects were categorized as having dementia or no dementia based on a battery of neuropsychological test results and clinical judgment. The isolated components needed for Level I and Level II diagnoses were then culled from the neuropsychological evaluations and independently used to designate PDD. Compared with traditional neuropsychological testing, the sensitivity and specificity of Level I criteria for PDD was 66.7% and 98.8%, and for Level II criteria 100% and 92.7%, respectively. Using Level II criteria, 6 additional subjects were diagnosed with PDD that were classified as having no dementia when full neuropsychological data were used for the diagnosis. These 6 subjects had more education years and were less impaired on cognitive tests. The Movement Disorder Society's Level II criteria more frequently classify subjects with PDD than does traditional neuropsychological testing. Whereas Level II criteria may overclassify subjects as having PDD, they are very accurate in ruling out dementia. Movement Disorder Society's criteria are practical and timesaving, although full neuropsychological testing may still be needed. © 2014 International Parkinson and Movement Disorder Society
Title: Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing
Description:
AbstractThe objective of our study was to compare Movement Disorder Society Task Force criteria for diagnosis of Parkinson's disease dementia (PDD) with the gold standard of traditional neuropsychological testing.
A short checklist (Level I) and a protocol of neuropsychological tests (Level II) have been proposed by a Movement Disorder Society Task Force but not fully validated in clinical practice.
Ninety‐one Parkinson's disease (PD) subjects were categorized as having dementia or no dementia based on a battery of neuropsychological test results and clinical judgment.
The isolated components needed for Level I and Level II diagnoses were then culled from the neuropsychological evaluations and independently used to designate PDD.
Compared with traditional neuropsychological testing, the sensitivity and specificity of Level I criteria for PDD was 66.
7% and 98.
8%, and for Level II criteria 100% and 92.
7%, respectively.
Using Level II criteria, 6 additional subjects were diagnosed with PDD that were classified as having no dementia when full neuropsychological data were used for the diagnosis.
These 6 subjects had more education years and were less impaired on cognitive tests.
The Movement Disorder Society's Level II criteria more frequently classify subjects with PDD than does traditional neuropsychological testing.
Whereas Level II criteria may overclassify subjects as having PDD, they are very accurate in ruling out dementia.
Movement Disorder Society's criteria are practical and timesaving, although full neuropsychological testing may still be needed.
© 2014 International Parkinson and Movement Disorder Society.
Related Results
Memory and executive function impairment predict dementia in Parkinson's disease
Memory and executive function impairment predict dementia in Parkinson's disease
AbstractWe analyzed the association of neuropsychological test impairment at baseline with the development of dementia in idiopathic Parkinson's disease (PD) patients. A cohort of ...
ENGAGE-DEM : a model of engagement of people with dementia
ENGAGE-DEM : a model of engagement of people with dementia
Dementia is a neurodegenerative disease that affects cognition, producing a reduction in thinking, problem-solving, and mnemonic abilities, functioning, preventing affected people ...
Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
Abstract
Pharmacotherapy of dementia is a critical intervention for managing symptoms of and slowing progression of dementia. However, evidence on prescribing patter...
Clinical validation of movement disorder society–recommended diagnostic criteria for Parkinson's disease with dementia
Clinical validation of movement disorder society–recommended diagnostic criteria for Parkinson's disease with dementia
AbstractThe objective of this work was to evaluate the Movement Disorders Society (MDS) Task Force–proposed screening checklist for detecting Parkinson's disease dementia (PD‐D) in...
MBI‐apathy, ApoEɛ2, and risk for Alzheimer disease dementia
MBI‐apathy, ApoEɛ2, and risk for Alzheimer disease dementia
AbstractBackgroundApathy, characterized by decreased interest, initiative, and emotional reactivity, is amongst the most common neuropsychiatric symptoms in dementia. However, apat...
Walking pace, handgrip strength, age, APOE genotypes, and new-onset dementia: the UK Biobank prospective cohort study
Walking pace, handgrip strength, age, APOE genotypes, and new-onset dementia: the UK Biobank prospective cohort study
Abstract
Background
The independent and additive associations of walking pace and grip strength on dementia risk and the potential modifying effects...
Prevalence, Factors Associated and Knowledge of Dementia in a Sample of Older Ugandans
Prevalence, Factors Associated and Knowledge of Dementia in a Sample of Older Ugandans
Abstract
Introduction:Dementia is on the rise due to increasing proportion of old people in Sub-Saharan Africa (SSA). Although dementia is misattributed to normal ageing or...
Journey to Diagnosis of Young-Onset Dementia: A Qualitative Study of People with Young-Onset Dementia and their Family Caregivers in Australia
Journey to Diagnosis of Young-Onset Dementia: A Qualitative Study of People with Young-Onset Dementia and their Family Caregivers in Australia
Objectives
This study aims to explore the journey to dementia diagnosis and reaction to the diagnosis from the perspective of people with young-onset dementia l...

